Diabetic gastroparesis is a complication of long-term diabetes characterized by delayed gastric emptying that is not associated with mechanical obstruction.
Epidemiology
Etiology
Pathophysiology
- Poor glycemic control, sustained hyperglycemia > 200 mg/dL → neuronal damage → impaired neural control of gastric function (e.g., interstitial cells of Cajal dysfunction, abnormal myenteric neurotransmission, smooth muscle dysfunction, vagal dysfunction) → antral motor coordination and function abnormalities (↓ antral contractions, pyloric spasms, abnormal antroduodenal contractions) → delayed gastric emptying
Clinical features
- Common symptoms
- Nausea and/or vomiting
- Bloating
- Upper abdominal pain
- Loss of appetite
- Early satiety
- Examination findings
- Abdominal distension
- Epigastric tenderness
- Succussion splash
- Complications
Diagnostics
Treatment
- Lifestyle: Small/frequent meals, low fiber, low fat. Strict glucose control.
- Metoclopramide (First-line)
- MOA: D2 receptor antagonist; ↑ resting tone, contractility, and LES tone.
- Adverse Effects: Extrapyramidal symptoms (parkinsonian features), Tardive Dyskinesia (irreversible; boxed warning), QT prolongation, hyperprolactinemia.
- Erythromycin t
- MOA: Motilin receptor agonist; stimulates high-amplitude gastric contractions.
- Use: Typically for acute exacerbations (IV) or short-term use.
- Limitation: Tachyphylaxis (tolerance) develops rapidly (usually <4 weeks).
- Antiemetics: Used for symptomatic relief of nausea (e.g., Ondansetron, Promethazine).
- Refractory: Gastric electrical stimulation.